GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » Pretax Margin %

Corix Bioscience (Corix Bioscience) Pretax Margin % : % (As of Sep. 2017)


View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Corix Bioscience's Pre-Tax Income for the three months ended in Sep. 2017 was $-0.52 Mil. Corix Bioscience's Revenue for the three months ended in Sep. 2017 was $0.00 Mil. Therefore, Corix Bioscience's pretax margin for the quarter that ended in Sep. 2017 was %.

The historical rank and industry rank for Corix Bioscience's Pretax Margin % or its related term are showing as below:


CXBS's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 4.06
* Ranked among companies with meaningful Pretax Margin % only.

Corix Bioscience Pretax Margin % Historical Data

The historical data trend for Corix Bioscience's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience Pretax Margin % Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
Pretax Margin %
Get a 7-Day Free Trial - - - - -638.33

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Corix Bioscience's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Corix Bioscience's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corix Bioscience's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Corix Bioscience's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Corix Bioscience's Pretax Margin % falls into.



Corix Bioscience Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Corix Bioscience's Pretax Margin for the fiscal year that ended in Dec. 2016 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2016 )/Revenue (A: Dec. 2016 )
=-4.43/0.694
=-638.33 %

Corix Bioscience's Pretax Margin for the quarter that ended in Sep. 2017 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2017 )/Revenue (Q: Sep. 2017 )
=-0.519/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Corix Bioscience  (GREY:CXBS) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Corix Bioscience Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Corix Bioscience (Corix Bioscience) Business Description

Traded in Other Exchanges
N/A
Address
18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines